393 related articles for article (PubMed ID: 28983816)
41. Genetically informed therapy in leukemia.
Radich J
N Engl J Med; 2013 May; 368(19):1838-9. PubMed ID: 23656651
[No Abstract] [Full Text] [Related]
42. CSF3R-mutated chronic neutrophilic leukemia: long-term outcome in 19 consecutive patients and risk model for survival.
Szuber N; Finke CM; Lasho TL; Elliott MA; Hanson CA; Pardanani A; Tefferi A
Blood Cancer J; 2018 Feb; 8(2):21. PubMed ID: 29449543
[No Abstract] [Full Text] [Related]
43. T618I-Mutated Colony Stimulating Factor 3 Receptor in Chronic Neutrophilic Leukemia and Chronic Myelomonocytic Leukemia Patients who Underwent Allogeneic Stem Cell Transplantation.
Lee SE; Jo I; Jang W; Kim Y; Han K; Kim M
Ann Lab Med; 2015 May; 35(3):376-8. PubMed ID: 25932451
[No Abstract] [Full Text] [Related]
44. Molecular genetics of chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemia.
Li B; Gale RP; Xiao Z
J Hematol Oncol; 2014 Dec; 7():93. PubMed ID: 25498990
[TBL] [Abstract][Full Text] [Related]
45. Molecular response of CSF3R T618I harboring chronic neutrophilic leukemia after induction chemotherapy linked to cord blood transplantation.
Kawashima I; Kumagai T; Suzuki M; Suzuki J; Koshiishi M; Nakajima K; Kirito K
Ann Hematol; 2019 Sep; 98(9):2249-2250. PubMed ID: 31240470
[No Abstract] [Full Text] [Related]
46. Chronic neutrophilic leukemia: 2018 update on diagnosis, molecular genetics and management.
Elliott MA; Tefferi A
Am J Hematol; 2018 Aug; 93(4):578-587. PubMed ID: 29512199
[TBL] [Abstract][Full Text] [Related]
47. T618I CSF3R mutations in chronic neutrophilic leukemia induce oncogenic signals through aberrant trafficking and constitutive phosphorylation of the O-glycosylated receptor form.
Price A; Druhan LJ; Lance A; Clark G; Vestal CG; Zhang Q; Foureau D; Parsons J; Hamilton A; Steuerwald NM; Avalos BR
Biochem Biophys Res Commun; 2020 Feb; 523(1):208-213. PubMed ID: 31848046
[TBL] [Abstract][Full Text] [Related]
48. Chronic neutrophilic leukemia 2016: Update on diagnosis, molecular genetics, prognosis, and management.
Elliott MA; Tefferi A
Am J Hematol; 2016 Mar; 91(3):341-9. PubMed ID: 26700908
[TBL] [Abstract][Full Text] [Related]
49. Current Management of Chronic Neutrophilic Leukemia.
Szuber N; Tefferi A
Curr Treat Options Oncol; 2021 Jun; 22(7):59. PubMed ID: 34097138
[TBL] [Abstract][Full Text] [Related]
50. Chronic neutrophilic leukemia in a child with a CSF3R T618I germ line mutation.
Druhan LJ; McMahon DP; Steuerwald N; Price AE; Lance A; Gerber JM; Avalos BR
Blood; 2016 Oct; 128(16):2097-2099. PubMed ID: 27581359
[No Abstract] [Full Text] [Related]
51. The CSF3R T618I mutation as a disease-specific marker of atypical CML post allo-SCT.
Langabeer SE; McCarron SL; Haslam K; O'Donovan MT; Conneally E
Bone Marrow Transplant; 2014 Jun; 49(6):843-4. PubMed ID: 24614839
[No Abstract] [Full Text] [Related]
52. Chronic neutrophilic leukemia: 2022 update on diagnosis, genomic landscape, prognosis, and management.
Szuber N; Elliott M; Tefferi A
Am J Hematol; 2022 Apr; 97(4):491-505. PubMed ID: 35089603
[TBL] [Abstract][Full Text] [Related]
53. Atypical chronic myeloid leukemia as defined in the WHO classification is a JAK2 V617F negative neoplasm.
Fend F; Horn T; Koch I; Vela T; Orazi A
Leuk Res; 2008 Dec; 32(12):1931-5. PubMed ID: 18555525
[TBL] [Abstract][Full Text] [Related]
54. Chronic Neutrophilic Leukemia: Current and Future Perspectives.
Venugopal S; Mascarenhas J
Clin Lymphoma Myeloma Leuk; 2019 Mar; 19(3):129-134. PubMed ID: 30581159
[TBL] [Abstract][Full Text] [Related]
55. De novo CSF3R mutation associated with transformation of myeloproliferative neoplasm to atypical CML.
Bartels S; Lehmann U; Büsche G; Schlue J; Hussein K; Debatin D; Karcher A; Andrulis M; Schirmacher P; Kreipe H
Ann Hematol; 2015 Jul; 94(7):1255-6. PubMed ID: 25865944
[No Abstract] [Full Text] [Related]
56. [Chronic neutrophilic leukemia complicated with multiple myeloma: two cases report and literature review].
Jiang B; Qi JY; Li QH; Xu Y; Sun MY; Zheng WW; Chen F; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2016 Aug; 37(8):688-91. PubMed ID: 27587251
[TBL] [Abstract][Full Text] [Related]
57. Clonal evolution in a chronic neutrophilic leukemia patient.
Zhang QG; Wang J; Gong WY; Jing QC
Hematology; 2019 Dec; 24(1):455-458. PubMed ID: 31076019
[TBL] [Abstract][Full Text] [Related]
58. [Diagnostic spectrum of Philadelphia-chromosome negative leukemic disorders].
Kvasnicka HM
Pathologe; 2002 Nov; 23(6):448-56. PubMed ID: 12436298
[TBL] [Abstract][Full Text] [Related]
59. [New mutations in myeloproliferative neoplasms; 2014 update].
Kirito K
Rinsho Ketsueki; 2014 Oct; 55(10):1833-40. PubMed ID: 25297747
[No Abstract] [Full Text] [Related]
60. Chronic neutrophilic leukemia and chronic myelomonocytic leukemia: WHO defined.
Elliott MA
Best Pract Res Clin Haematol; 2006; 19(3):571-93. PubMed ID: 16781489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
